KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,243,357 | +7.0% | 856,008 | 0.0% | 0.90% | +69.7% |
| Q2 2023 | $7,704,072 | +14.5% | 856,008 | 0.0% | 0.53% | +13.9% |
| Q1 2023 | $6,728,223 | +116164.4% | 856,008 | 0.0% | 0.47% | -29.9% |
| Q4 2022 | $5,787 | -100.0% | 856,008 | -44.2% | 0.67% | -72.9% |
| Q3 2022 | $22,252,000 | +47.5% | 1,533,559 | 0.0% | 2.46% | +62.2% |
| Q2 2022 | $15,090,000 | -33.2% | 1,533,559 | 0.0% | 1.52% | -2.7% |
| Q1 2022 | $22,605,000 | +11.4% | 1,533,559 | 0.0% | 1.56% | +27.3% |
| Q4 2021 | $20,289,000 | -29.2% | 1,533,559 | -6.6% | 1.22% | -4.9% |
| Q3 2021 | $28,651,000 | -35.8% | 1,641,913 | -11.9% | 1.29% | -33.5% |
| Q2 2021 | $44,645,000 | -6.7% | 1,863,296 | 0.0% | 1.93% | +14.9% |
| Q1 2021 | $47,868,000 | +55.8% | 1,863,296 | +15.1% | 1.68% | +22.7% |
| Q4 2020 | $30,731,000 | +65.3% | 1,618,296 | +9.6% | 1.37% | +27.7% |
| Q3 2020 | $18,593,000 | +4.1% | 1,476,796 | 0.0% | 1.07% | -16.2% |
| Q2 2020 | $17,869,000 | +58.2% | 1,476,796 | 0.0% | 1.28% | +25.2% |
| Q1 2020 | $11,297,000 | -62.5% | 1,476,796 | +8.7% | 1.02% | -63.7% |
| Q2 2019 | $30,105,000 | -22.6% | 1,359,149 | 0.0% | 2.82% | -27.3% |
| Q1 2019 | $38,899,000 | +44.9% | 1,359,149 | 0.0% | 3.88% | +13.2% |
| Q4 2018 | $26,843,000 | -10.7% | 1,359,149 | 0.0% | 3.43% | +13.2% |
| Q3 2018 | $30,051,000 | +1132.1% | 1,359,149 | +352.6% | 3.03% | +864.6% |
| Q2 2018 | $2,439,000 | -14.3% | 300,325 | 0.0% | 0.31% | -22.1% |
| Q1 2018 | $2,847,000 | -2.8% | 300,325 | 0.0% | 0.40% | -35.7% |
| Q4 2017 | $2,928,000 | +44.9% | 300,325 | 0.0% | 0.63% | +53.7% |
| Q3 2017 | $2,021,000 | -13.9% | 300,325 | 0.0% | 0.41% | -40.9% |
| Q1 2017 | $2,346,000 | +10.5% | 300,325 | 0.0% | 0.69% | -1.4% |
| Q4 2016 | $2,123,000 | – | 300,325 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,810,246 | $17,432,669 | 7.30% |
| TCG Crossover Management, LLC | 3,395,495 | $32,698,617 | 4.82% |
| TANG CAPITAL MANAGEMENT LLC | 3,440,345 | $33,130,522 | 4.68% |
| VR Adviser, LLC | 2,916,667 | $28,087,503 | 2.96% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $31,190,212 | 2.07% |
| Nan Fung Group Holdings Ltd | 234,573 | $2,258,938 | 1.83% |
| DAFNA Capital Management LLC | 605,532 | $5,831,273 | 1.81% |
| Opaleye Management Inc. | 500,000 | $4,815,000 | 1.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 530,400 | $5,107,752 | 1.55% |
| MPM BioImpact LLC | 577,958 | $5,565,736 | 1.49% |